Episodes 166-180 of 253
Challenges in DMD: Understanding the Height Factor
NeuroFrontiersChallenges in DMD: Understanding the Height Factor
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Project Oncology®Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
NeuroFrontiersNKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
Diagnosing IgAN: The Importance of Early and Accurate Identification
Clinician's RoundtableDiagnosing IgAN: The Importance of Early and Accurate Identification
Investigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
Clinician's RoundtableInvestigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
Diagnosing Castleman Disease: Key Considerations
Project Oncology®Diagnosing Castleman Disease: Key Considerations
- advertisement
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Project Oncology®Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
IgAN Explained: Key Differences from Other Kidney Conditions
Clinician's RoundtableIgAN Explained: Key Differences from Other Kidney Conditions
Nutritional Strategies for Managing IgA Nephropathy
Clinician's RoundtableNutritional Strategies for Managing IgA Nephropathy
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
NeuroFrontiersZilucoplan: A Promising Potential Treatment for Myasthenia Gravis
Rare Kidney Disease: A Parent and Caregiver’s Perspective
Clinician's RoundtableRare Kidney Disease: A Parent and Caregiver’s Perspective
Decoding Proteinuria: A Window into Kidney Health in IgAN
Clinician's RoundtableDecoding Proteinuria: A Window into Kidney Health in IgAN
- advertisement
Reducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
NeuroFrontiersReducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
ATTR Peripheral Neuropathy: How to Avoid Misdiagnosis
NeuroFrontiersATTR Peripheral Neuropathy: How to Avoid Misdiagnosis
Advances in IgAN: New Frontiers in Biomarkers and Treatment
On the Frontlines of IgA NephropathyAdvances in IgAN: New Frontiers in Biomarkers and Treatment
